BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12924458)

  • 1. Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada.
    Jackson LD; Groome PA; Schulze K; O'Sullivan B; Irish JC; Dixon PF; Eapen LJ; Gulavita SP; Hammond JA; Hodson DI; Mackenzie RG; Bissett RJ; Schneider KM; Warde PR; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):266-79. PubMed ID: 12924458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid dosimetry for T1 glottic cancer radiotherapy.
    Garcez K; Lim CC; Whitehurst P; Thomson D; Ho KF; Lowe M; Sykes A; Lee LW; Yap B; Slevin N
    Br J Radiol; 2014 Jun; 87(1038):20130754. PubMed ID: 24628251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.
    Tong CC; Au KH; Ngan RK; Chow SM; Cheung FY; Fu YT; Au JS; Law SC
    Radiat Oncol; 2011 May; 6():53. PubMed ID: 21600025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.
    Bledsoe TJ; Park HS; Stahl JM; Yarbrough WG; Burtness BA; Decker RH; Husain ZA
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.
    Groome PA; O'Sullivan B; Mackillop WJ; Jackson LD; Schulze K; Irish JC; Warde PR; Schneider KM; Mackenzie RG; Hodson DI; Hammond JA; Gulavita SP; Eapen LJ; Dixon PF; Bissett RJ
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1002-12. PubMed ID: 16414205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of radiotherapy for T1 glottic cancers; influence of radiation beam energy.
    Yamamoto M; Joja I; Takemoto M; Kuroda M; Hiraki Y
    Acta Med Okayama; 1999 Apr; 53(2):91-4. PubMed ID: 10358724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could changes in clinical practice reduce waiting lists for radiotherapy?
    Dixon P; Mackillop W
    J Health Serv Res Policy; 2001 Apr; 6(2):70-7. PubMed ID: 11357247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
    Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
    Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
    Dinshaw KA; Sharma V
    Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.
    Sommat K; Yit NL; Kwok LL
    Laryngoscope; 2017 May; 127(5):1061-1067. PubMed ID: 27237064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the management of carcinoma in situ of the glottic larynx.
    Medini E; Medini I; Lee CK; Gapany M; Levitt SH
    Am J Clin Oncol; 1998 Jun; 21(3):298-301. PubMed ID: 9626803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?
    Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Math KS; Bissett RJ; Dixon PR; Eapen LJ; Gulavita SP; Hammond JA; Hodson DI; Mackenzie RG; Schneider KM; Warde PR; Mackillop WJ
    J Clin Epidemiol; 2001 Mar; 54(3):301-15. PubMed ID: 11223328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.